Companies capable of hypergrowth often see their stock prices bid up to outrageous levels. Often, however, shares remain a ...

There’s no getting around it. Shares of America’s largest companies have been looking pretty expensive lately.

There will be others, especially as its bottom line and free cash flow are impressive. The company's net income grew by 54.5% ...

While it will be at least a few years before those more powerful gene editing therapies get approved for sale, assuming they ever are ... that possibility is another solid reason to buy the stock ...